Thymulin (also known as thymic factor or facteur thymique serique) is a naturally occurring nonapeptide hormone produced by the epithelial cells of the thymus gland. It plays a key role in immune regulation, particularly in the differentiation, maturation, and function of T-lymphocytes (T-cells). Its amino acid sequence is: Pyr-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn.

Chemical Structure:

• Pyr = Pyroglutamic acid (a cyclized form of glutamic acid).
• Molecular formula: C41H67N15O16.
• Molecular weight: ~858 Da.

Thymulin requires zinc (Zn²⁺) as a cofactor for full biological activity; the zinc-bound form (Zn-thymulin) is the active version.

Biological Functions

• T-Cell Regulation: Promotes the differentiation of thymocytes into mature T-cells and enhances T-cell responses to antigens.
• Cytokine Modulation: Influences production of interleukins (e.g., IL-2) and interferon-gamma (IFN-γ).
• Anti-Inflammatory Effects: Reduces inflammation in autoimmune models and may counteract age-related immune decline (immunosenescence).
• Neuroendocrine Links: Crosses the blood-brain barrier and modulates neuroendocrine functions, potentially affecting pain perception and behavior.

Evidence:

• Discovered in 1977 by Bach et al. (PNAS, 1977).
• Studies show thymulin levels peak in childhood and decline with age, correlating with thymic involution (e.g., Dardenne et al., 1982, Immunology).

Potential Therapeutic Uses

Thymulin and synthetic analogs (e.g., PAT, a stable analog) are researched for:

• Immunodeficiencies: Restoring T-cell function in aging or HIV.
• Autoimmune Diseases: Rheumatoid arthritis, multiple sclerosis (preclinical rodent models show reduced symptoms).
• Cancer Immunotherapy: Enhancing anti-tumor T-cell responses.
• Neuroprotection: Preliminary studies suggest benefits in Alzheimer’s models via anti-inflammatory effects (e.g., Ratnakar et al., 2010).

Clinical Status:

• Not FDA-approved for human use.
• Mostly in preclinical/early clinical stages. Some trials explored subcutaneous thymulin in immunodeficient patients (e.g., 1980s French studies), but no large-scale approvals.
• Available as research peptides from suppliers like Peptide Sciences or Sigma-Aldrich (purity >98%, typically lyophilized powder reconstituted in bacteriostatic water).

Dosing (Research Contexts Only):

Side Effects & Safety

• Low Toxicity: Animal studies show minimal adverse effects at physiological doses.
• Potential Risks: Overstimulation of immune response could exacerbate autoimmunity; zinc interactions.
• Contraindications: Avoid in thymoma or active infections without medical supervision.
• Human data limited; consult a physician before use.

Recent Research Highlights

• 2020s Studies: Thymulin analogs show promise in COVID-19 immune dysregulation (e.g., enhancing T-cell exhaustion reversal; Front Immunol, 2021).
• Aging: Restores thymic function in aged mice (J Gerontol, 2018).
• Patents: Several for stabilized analogs (e.g., US Patent 10,000,000+ series).

For sourcing or protocols, refer to PubMed (search “thymulin peptide”) or Examine.com. Always prioritize lab-tested products and professional advice—this is not medical guidance. If you have a specific aspect (e.g., synthesis, studies), let me know!